COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

ABSTRACT: Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific breakthrough, the journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant policy challenges that require a collaborative, global response. We offer a framework for understanding remaining and new policy challenges for successful global vaccine campaigns against COVID-19 as well as potential solutions to address them. Decision-makers must be aware of these challenges and strategize solutions that can be implemented at scale. These include challenges aro

SUBMITTER: Forman R 

PROVIDER: S-EPMC7997052 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature